Inventor · disambiguated record
Douglas Ringler
Also filed as: RINGLER DOUGLAS · RINGLER DOUGLAS J · RINGLER DOUGLAS J V
10 granted patents·10 pending applications·197 citations·filing 1995–2010
89Inventor score
Top patents by PatentIndex Score
20 records- 0191US7147851B1Humanized immunoglobulin reactive with α4β7 integrinMILLENNIUM PHARM INC·Filed 1996·Granted Dec 12, 2006·83 cites·9 claims
- 0290US7402410B2Humanized immunoglobulin reactive with α4β7 integrinMILLENNIUM PHARM INC·Filed 2006·Granted Jul 22, 2008·12 cites·23 claims
- 0388US6551593B1Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcamMILLENNIUM PHARM INC·Filed 1995·Granted Apr 22, 2003·79 cites·22 claims
- 0478US7423129B2Antibodies to human eotaxinMILLENNIUM PHARM INC·Filed 2007·Granted Sep 9, 2008·1 cites·10 claims
- 0571US7947272B2Compositions and methods of tolerizing a primate to an antigenTOLERX INC·Filed 2006·Granted May 24, 2011·1 cites·21 claims
- 0669US7858326B2Method of diagnosis of inflammatory disease using eotaxin antibodiesMILLENNIUM PHARM INC·Filed 2008·Granted Dec 28, 2010·0 cites·7 claims
- 0762US7265201B1Human chemotactic cytokineMILLENNIUM PHARM INC·Filed 1995·Granted Sep 4, 2007·8 cites·5 claims
- 0862US2009011464A1Humanized immunoglubulin reactive with alph4beta7 integrinMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 0961US7803904B2Mucosal vascular addressing and uses thereofMILLENNIUM PHARM INC·Filed 1996·Granted Sep 28, 2010·13 cites·60 claims
- 1060US7285620B2Human chemotactic cytokineMILLENNIUM PHARM INC·Filed 2005·Granted Oct 23, 2007·0 cites·18 claims
- 1156US7541443B2Anti-CD4 antibodiesTOLERRX INC·Filed 2003·Granted Jun 2, 2009·0 cites·13 claims
- 1252US2006057135A1Mucosal vascular addressins and uses thereofBRISKIN MICHAEL J·Filed 2005·Application pending·0 cites
- 1351US2008112949A1Optimized dosing with anti-CD4 antibodies for tolerance induction in primatesTOLERX INC·Filed 2007·Application pending·0 cites
- 1448US2004175381A1Inducing tolerance in primatesTOLERRX INC·Filed 2003·Application pending·0 cites
- 1546US2002172679A1Treatment of inflammatory bowel disease by inhibiting binding and/or signalling through alpha4beta7 and its ligands and MAdCAMMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1646US2006002921A1Optimized dosing with anti-CD4 antibodies for tolerance induction in primatesTOLERRX INC·Filed 2005·Application pending·0 cites
- 1744US2011008330A1Compositions and methods of tolerizing a primate to an antigenFREWIN MARK·Filed 2010·Application pending·0 cites
- 1843US2003108518A1TRX1 antibody and uses thereforFiled 2002·Application pending·0 cites
- 1933US2012269826A1Anti-cd3 antibody dosing in autoimmune diseaseMCKEE CHARLOTTE·Filed 2010·Application pending·0 cites
- 2029US2013171142A1Methods of using anti-cd3 antibodies to prevent weight gainBRENNAN AOIFE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas Ringler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →